NEA Management Company’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History

NEA Management Company’s Portfolio PHXM Stock Details PHXM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-62,500	Closed	-$3.61M	–	66
2021 Q3	$3.61M	Hold	62,500	–	–	0.04%	58
2021 Q2	$3.02M	Hold	62,500	–	–	0.04%	58
2021 Q1	$4.4M	Hold	62,500	–	–	0.1%	54
2020 Q4	$5.77M	Hold	62,500	–	–	0.15%	52
2020 Q3	$3.75M	Hold	62,500	–	–	0.16%	45
2020 Q2	$5.72M	Hold	62,500	–	–	0.23%	38
2020 Q1	$3.34M	Hold	62,500	–	–	0.17%	43
2019 Q4	$4.61M	Hold	62,500	–	–	0.22%	39
2019 Q3	$2.64M	Hold	62,500	–	–	0.22%	39
2019 Q2	$4.47M	Hold	62,500	–	–	0.31%	34
2019 Q1	$4.74M	Hold	62,500	–	–	0.25%	38
2018 Q4	$4.23M	Hold	62,500	–	–	0.17%	38
2018 Q3	$5.36M	Hold	62,500	–	–	0.23%	39
2018 Q2	$6.98M	Hold	62,500	–	–	0.33%	38
2018 Q1	$13.1M	Hold	62,500	–	–	0.58%	26
2017 Q4	$13.8M	Buy	+62,500	New	+$14.8M	0.57%	26

Other funds holding PHXM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

NEA Management Company's PHXM Position: Q4 2021 in Review

NEA Management Company sold out of PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) in Q4 2021, closing a stake of 62,500 shares — an estimated $3.61M sold.

NEA Management Company first reported a position in PHXM in Q4 2017 and held it in 16 quarters. The position peaked at $13.8M in Q4 2017. 9 funds tracked by Wall St. Rank hold PHXM as of Q4 2021.

NEA Management Company reported no remaining PHAXIAM Therapeutics S.A.. American Depositary Shares position as of Q4 2021 after selling out during the quarter.
NEA Management Company sold 62,500 PHAXIAM Therapeutics S.A.. American Depositary Shares shares in Q4 2021, an estimated $3.61M.
NEA Management Company first reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares in Q4 2017 and held it in 16 quarters.
NEA Management Company's PHAXIAM Therapeutics S.A.. American Depositary Shares position peaked at $13.8M in Q4 2017.
9 funds tracked by Wall St. Rank held PHAXIAM Therapeutics S.A.. American Depositary Shares as of Q4 2021.

Based on NEA Management Company's 13F filing for Q4 2021, filed 14 Feb 2022.